Guided Therapeutics (GTHP) EPS (Weighted Average and Diluted) (2015 - 2025)
Guided Therapeutics recorded quarterly EPS (Weighted Average and Diluted) of -$0.01 in Q4 2025, little changed quarter-over-quarter from -$0.01 in Q3 2025, and up 50.0% year-over-year from -$0.01 in Q4 2024.
Guided Therapeutics' EPS (Weighted Average and Diluted) history runs 11 years deep, the most recent figure standing at -$0.01 for Q4 2025.
- In Q4 2025, EPS (Weighted Average and Diluted) rose 50.0% year-over-year to -$0.01; the TTM figure through Dec 2025 stood at -$0.04 (up 20.0% YoY), while the FY2025 annual figure was -$0.04, up 20.0% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.01 for Q4 2025 at Guided Therapeutics, roughly flat from -$0.01 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.0 in Q3 2021 to a low of -$0.09 in Q2 2021.
- A 5-year average of -$0.02 and a median of -$0.02 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) jumped 84.21% in 2021 and plunged 689.24% in 2022, its largest moves.
- Guided Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.04 in 2021, then declined by 0.0% to -$0.04 in 2022, then surged by 77.07% to -$0.01 in 2023, then plunged by 118.04% to -$0.02 in 2024, then soared by 50.0% to -$0.01 in 2025.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$0.01, -$0.01, and -$0.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.04 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.04 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -0.09 |
| Mar 31, 2021 | -0.04 |
| Dec 31, 2020 | 0.21 |
| Sep 30, 2020 | 0.03 |
| Jun 30, 2020 | -0.57 |
| Mar 31, 2020 | 0.04 |
| Dec 31, 2019 | 0.33 |
| Sep 30, 2019 | -0.04 |
| Jun 30, 2019 | -0.81 |
| Mar 31, 2019 | -0.07 |
| Dec 31, 2018 | -0.26 |
| Sep 30, 2018 | -1.60 |
| Jun 30, 2018 | 1.24 |
| Mar 31, 2018 | 0.00 |
| Dec 31, 2017 | 1.43 |
| Sep 30, 2017 | -0.35 |
| Jun 30, 2017 | -0.59 |
| Mar 31, 2017 | -0.22 |
| Sep 30, 2016 | -1.36 |
| Jun 30, 2016 | -52.95 |
| Mar 31, 2016 | -3.09 |
| Sep 30, 2015 | -1.75 |
| Jun 30, 2015 | -0.03 |
| Mar 31, 2015 | -1.31 |